Murray, E. M., Cyr, D., Fudim, M., Ward, J. H., Hernandez, A. F., Lepage, S., … Mentz, R. J. (2024). Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEF. JACC. Advances, 3(6).

Murray, Evan M., Derek Cyr, Marat Fudim, Jonathan H. Ward, Adrian F. Hernandez, Serge Lepage, David A. Morrow, et al. “Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEF.” JACC. Advances 3, no. 6 (May 2024).

Murray EM, Cyr D, Fudim M, Ward JH, Hernandez AF, Lepage S, et al. Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEF. JACC Advances. 2024 May;3(6).

Murray, Evan M., et al. “Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEF.” JACC. Advances, vol. 3, no. 6, May 2024.

Murray EM, Cyr D, Fudim M, Ward JH, Hernandez AF, Lepage S, Morrow DA, Starling RC, Williamson KM, Desai AS, Zieroth S, Solomon SD, Mentz RJ. Effects of Sacubitril/Valsartan vs Valsartan in De Novo vs Acute on Chronic HFpEF and HFmrEF. JACC Advances. 2024 May;3(6).